British Society for Immunology response to The Lancet paper on interim phase 3 trial results for the University of Oxford/AstraZeneca COVID-19 vaccine
BSI response to announcement that the Pfizer-BioNTech COVID-19 vaccine has been approved for use in the UK.
British Society for Immunology response to interim phase 3 results from the AstraZeneca/University of Oxford trial for the ChAdOx1 nCoV-19 vaccine against COVID-19.
British Society for Immunology response to phase 2/3 results from the AstraZeneca/University of Oxford trial for theChAdOx1 nCoV-19 vaccine against COVID-19
Press release on BSI report on the ageing immune system and COVID-19
BSI response to new pre-print study from UK-CIC researchers suggesting cellular immunity against SARS-CoV-2 is present six months after asymptomatic or mild/moderate COVID-19 infection.
BSI response to the first human challenge studies for COVID-19.
The Nobel Prize in Physiology or Medicine 2020 has been awarded to Harvey J. Alter (National Institutes of Health, Bethesda, MD, USA), Michael Houghton (University of Alberta, Edmonton, Canada) and Charles M. Rice (Rockefeller University, New York, NY, USA) “for the discovery of Hepatitis C virus”.
Our response to new survey by University College London reporting that a fifth of people are unlikely to get vaccinated against COVID-19.
NHS Digital has released the annual report on NHS Immunisation Statistics, England, 2019–20 today. In response, the British Society for Immunology has released the following statement.
BSI response to news that the AstraZeneca-Oxford University coronavirus vaccine trial has been paused to investigate an unexplained illness in one participant.
New national immunology consortium to tackle COVID-19
British Society for Immunology response to new study on new-onset type 1 diabetes in children during COVID-19
British Society for Immunology response to the creation of a new National Institute for Health Protection
British Society for Immunology briefing note highlighting that urgent research into the long-term immunological health consequences of COVID-19 is crucial to prevent placing an additional burden on the NHS in the future.